Article · 4 May 2026
ArticlePublished 3 Aug 2024
Expression Changes of microRNA-499 in H9C2 Cardiomyocytes with Anoxia-Reoxygenation Injury and Anti-Apoptosis Regulation Mechanism
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To determine the relative expression of microRNA-499 after anoxia-reoxygenation injury and to investigate the anti-apoptotic regulatory mechanism. The anoxia-reoxygenation injury model of H9C2 cardiomyocytes was developed, including two groups; normoxia and anoxia-reoxygenation. Real-time polymerase chain reaction was used to detect the expression trend of microRNA-499 after hypoxia and anoxia-reoxygenation injury; different concentrations of microRNA-499 mimic were transfected and the cell survival was detected. The target gene of microRNA-499 was confirmed by luciferase reporter gene assay. The expression and effect on apoptosis were detected by real-time polymerase chain reaction and Western blot. The expression of microRNA-499 peaked at 24 h of hypoxia and 9 h of reoxygenation in H9C2 cardiomyocytes. MicroRNA-499 had an optimal protective effect against anoxia-reoxygenation injury when transfected at a concentration of 100 nm. In addition, microRNA-499 down-regulated the expression of target genes Jun N-terminal protein kinase and caspase-3 after anoxia-reoxygenation injury. Overexpression of microRNA-499 reduced anoxiareoxygenation- induced H9C2 cardiomyocyte injury, which may be related to the inhibition of apoptosis in H9C2 cardiomyocytes through the modulation of the Jun N-terminal protein kinase/caspase-3 pathway.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chongzhou Zheng”
- BylineArticles whose byline prints “Fei Huang”
- BylineArticles whose byline prints “Kunpeng Zhu”
- BylineArticles whose byline prints “Zhongkai He”
- BylineArticles whose byline prints “Ming Li”
- BylineArticles whose byline prints “Feng Yao”